Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB

Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials